275 related articles for article (PubMed ID: 8071050)
1. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
[TBL] [Abstract][Full Text] [Related]
2. A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
Druy EM; Bettmann MA; Jeans W
Invest Radiol; 1994 May; 29 Suppl 1():S102-5; discussion S106. PubMed ID: 8071036
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study of the safety, tolerance, and diagnostic efficacy of iopromide as compared with iopamidol and iohexol in patients requiring aortography and visceral angiography.
Faykus MH; Cope C; Athanasoulis C; Druy EM; Hedgcock M; Miller FJ; Bron K
Invest Radiol; 1994 May; 29 Suppl 1():S98-101; discussion S106. PubMed ID: 8071053
[TBL] [Abstract][Full Text] [Related]
4. Comparison of iopromide with iohexol and iopamidol in coronary arteriography and left ventriculography.
Bergelson B; Bettmann MA; Wexler L; Wilson R; Dyet J
Invest Radiol; 1994 May; 29 Suppl 1():S107-11; discussion S118-9. PubMed ID: 8071037
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of iopromide for excretory urography.
Newhouse JH; Landman J; Lang E; Amis ES; Goldman S; Khazan R; Leder R; Hedgcock M
Invest Radiol; 1994 May; 29 Suppl 1():S68-73. PubMed ID: 8071049
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of iopromide in cerebral arteriography.
Haughton VM; Papke RA; Hyland D; Drayer BP; Osborn AG; Maravilla K; Hilal SK
Invest Radiol; 1994 May; 29 Suppl 1():S94-7. PubMed ID: 8071052
[TBL] [Abstract][Full Text] [Related]
7. Double-blind study of a new nonionic contrast agent for digital subtraction arteriography.
Weiss JP; McLean GK; Modic MT; Rees CR; Higashida RT
Invest Radiol; 1994 May; 29 Suppl 1():S84-92. PubMed ID: 8071051
[TBL] [Abstract][Full Text] [Related]
8. [Tolerability of nonionic contrast media--results of a multicenter double blind study].
Schmiedel E
Aktuelle Radiol; 1992 May; 2(3):148-52. PubMed ID: 1610929
[TBL] [Abstract][Full Text] [Related]
9. A randomised, double-blind trial of iomeprol and iopromide in intravenous excretory urography.
Harding JR; Bertazzoli M; Spinazzi A
Eur J Radiol; 1994 May; 18 Suppl 1():S93-6. PubMed ID: 8020526
[TBL] [Abstract][Full Text] [Related]
10. Pharmacochemical profile of iopromide.
Muetzel W; Speck U
AJNR Am J Neuroradiol; 1983; 4(3):350-2. PubMed ID: 6410742
[TBL] [Abstract][Full Text] [Related]
11. Iomeprol: current and future profile of a radiocontrast agent.
Katayama H; Spinazzi A; Fouillet X; Kirchin MA; Taroni P; Davies A
Invest Radiol; 2001 Feb; 36(2):87-96. PubMed ID: 11224756
[TBL] [Abstract][Full Text] [Related]
12. A double-blind study comparing the efficiency, tolerance and renal effects of iopromide and iopamidol.
Kennedy C; Rickards D; Lee S; Sharp MB; Dawson P
Br J Radiol; 1988 Apr; 61(724):288-93. PubMed ID: 3285943
[TBL] [Abstract][Full Text] [Related]
13. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study.
Velázquez MT; Albarrán A; Hernández F; García Tejada J; Zueco J; Andreu J; De la Torre JM; Figueroa A; Sainz F; Tascón J
Acta Cardiol; 2010 Aug; 65(4):387-94. PubMed ID: 20821930
[TBL] [Abstract][Full Text] [Related]
14. Iomeprol versus iopromide for intravenous urography.
de Geeter P; Melchior H
Br J Radiol; 1994 Oct; 67(802):958-63. PubMed ID: 8000839
[TBL] [Abstract][Full Text] [Related]
15. Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department.
García M; Aguirre U; Martinez A; Ruiz B; Lertxundi U; Aguirre C
Br J Radiol; 2014 Jan; 87(1033):20130511. PubMed ID: 24191124
[TBL] [Abstract][Full Text] [Related]
16. Clinical tolerance and diagnostic efficacy of iobitridol 300 in lower limb angiography.
Stockx L; Wilms G; Baert AL; Terrier F
Acta Radiol Suppl; 1996; 400():72-4. PubMed ID: 8619357
[TBL] [Abstract][Full Text] [Related]
17. Renal and hepatic tolerance of nonionic and ionic contrast media in intravenous digital subtraction angiography.
Langer M; Junge W; Keysser R; Hasford J; Jänicke UA
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():95-100. PubMed ID: 2568817
[TBL] [Abstract][Full Text] [Related]
18. Renal excretion of iopromide and iopamidol after intravenous administration in digital subtraction angiography.
Mützel W; Langer M; Keysser R
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():101-4. PubMed ID: 2568774
[TBL] [Abstract][Full Text] [Related]
19. Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE).
Palkowitsch P; Lengsfeld P; Stauch K; Heinsohn C; Kwon ST; Zhang SX; Liang CH
Acta Radiol; 2012 Mar; 53(2):179-86. PubMed ID: 22184683
[TBL] [Abstract][Full Text] [Related]
20. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
